|
Volumn , Issue 7, 2002, Pages 498-520
|
Cardiovascular disease in diabetes.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY BYPASS GRAFT;
DIABETIC ANGIOPATHY;
HEALTH BEHAVIOR;
HUMAN;
LIFESTYLE;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
STENT;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
COMBINED MODALITY THERAPY;
CORONARY ARTERIOSCLEROSIS;
CORONARY ARTERY BYPASS;
DIABETIC ANGIOPATHIES;
HEALTH BEHAVIOR;
HUMANS;
LIFE STYLE;
PLATELET AGGREGATION INHIBITORS;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
STENTS;
TREATMENT OUTCOME;
|
EID: 0036599414
PISSN: 14623846
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (61)
|